SELLAS Life Sciences Group, Inc.

NORTHERN TRUST CORP SLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

930,750

Value ($000)

3,509

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	3,509	0.0%	930,750	12/31/2025
2025 Q3	11/14/2025	1,177	0.0%	731,175	9/30/2025
2025 Q2	8/13/2025	1,530	0.0%	698,493	6/30/2025
2025 Q1	5/13/2025	178	0.0%	164,390	3/31/2025
2024 Q4	2/14/2025	140	0.0%	134,721	12/31/2024
2024 Q3	11/13/2024	126	0.0%	100,843	9/30/2024
2024 Q2	8/14/2024	120	0.0%	100,843	6/30/2024
2024 Q1	5/14/2024	90	0.0%	88,730	3/31/2024
2023 Q4	2/13/2024	66	0.0%	62,437	12/31/2023
2023 Q3	11/13/2023	65	0.0%	39,360	9/30/2023
2023 Q2	8/11/2023	62	0.0%	39,360	6/30/2023
2023 Q1	5/15/2023	43	0.0%	30,018	3/31/2023
2022 Q4	2/13/2023	89	0.0%	37,671	12/31/2022
2022 Q3	11/14/2022	76	0.0%	37,671	9/30/2022
2022 Q2	8/12/2022	55	0.0%	24,605	6/30/2022
2022 Q1	5/13/2022	165	0.0%	24,820	3/31/2022
2021 Q4	2/8/2022	136	0.0%	24,605	12/31/2021
2021 Q3	11/15/2021	225	0.0%	24,605	9/30/2021
2021 Q2	8/13/2021	273	0.0%	24,605	6/30/2021
2021 Q1	5/12/2021	155	0.0%	18,110	3/31/2021
2020 Q4	2/11/2021	94	0.0%	16,232	12/31/2020